Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Launched by UNIVERSITY OF PENNSYLVANIA · Apr 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Using the EHR to Advance Genomic Medicine Across a Diverse Health System," is exploring a new way to make genetic testing more accessible and useful for patients with certain health conditions, such as genetic predisposition to diseases like paraganglioma, pheochromocytoma, Alzheimer's, and more. The goal is to find better methods for healthcare providers to order and share genetic testing results through electronic health records (EHR), which could improve the way patients are cared for based on their genetic information. This trial is innovative because it looks at using technology and behavioral strategies to encourage both doctors and patients to engage more with genetic testing.
To be eligible for this trial, participants need to be at least 18 years old and have been diagnosed with one of the specific conditions being studied. If you join, you can expect to work with your healthcare team to see how this new approach to genetic testing might change your treatment options. The trial is currently recruiting participants and aims to create a better system for providing genomic medicine, which is the use of genetic information in medical care, to help improve health outcomes for individuals with these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • diagnosed with one of the study conditions
- Exclusion Criteria:
- • Under 18 years of age
- • not diagnosed with one of the study conditions
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Katherine L Nathanson, MD
Principal Investigator
University of Pennsylva
Robert Schnoll, PhD
Principal Investigator
University of Pennsylva
Marylyn Ritchie, PhD
Principal Investigator
University of Pennsylva
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported